Participating Companies

(Partial list as of May 22, 2018; subject to change)

ACADIA Pharmaceuticals Inc. (ACAD)
Achillion Pharmaceuticals, Inc. (ACHN)
Aclaris Therapeutics, Inc. (ACRS)
Adamas Pharmaceuticals, Inc. (ADMS)
Aerie Pharmaceuticals, Inc. (AERI)
Aerpio Pharmaceuticals, Inc. (ARPO)
Aevi Genomic Medicine, Inc. (GNMX)
Aimmune Therapeutics, Inc. (AIMT)
Akebia Therapeutics, Inc. (AKBA)
Alzheon, Inc. (Private)
Arbutus Biopharma Corporation (ABUS)
Arcturus Therapeutics Ltd. (ARCT)
Ardelyx, Inc. (ARDX)
Arena Pharmaceuticals, Inc. (ARNA)
argenx SE  (ARGX)
ArQule, Inc. (ARQL)
Arrowhead Pharmaceuticals, Inc. (ARWR)
Avadel Pharmaceuticals plc (AVDL)
Avelas Biosciences (Private)
AxoGen, Inc.  (AXGN)
Axonics (Private)
Axovant Sciences Ltd. (AXON)
Bellerophon Therapeutics, Inc. (BLPH)
BioCryst Pharmaceuticals, Inc. / Idera Pharmaceuticals, Inc. (BCRX / IDRA)
BioLineRx Ltd (BLRX)
Bovie Medical Corporation (BVX)
Caelum Biosciences, Inc. (Private)
Calithera Biosciences, Inc.  (CALA)
Catalyst Biosciences, Inc. (CBIO)
Checkpoint Therapeutics, Inc. (CKPT)
ChemoCentryx, Inc. (CCXI)
Clearside Biomedical, Inc. (CLSD)
Compugen Ltd. (CGEN)
Concert Pharmaceuticals, Inc.  (CNCE)
ContraFect Corporation (CFRX)
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
CRISPR Therapeutics AG (CRSP)
CTI BioPharma Corp. (CTIC)
CymaBay Therapeutics (CBAY)
Cytokinetics, Incorporated (CYTK)
DBV Technologies S.A. (DBVT)
Deciphera Pharmaceuticals, Inc. (DCPH)
Dermavant Sciences, Inc. (Private)
Editas Medicine, Inc. (EDIT)
Egalet Corporation (EGLT)
EIP Pharma (Private)
Enanta Pharmaceuticals, Inc. (ENTA)
Erytech Pharma S.A. (ERYP)
Esperion Therapeutics, Inc. (ESPR)
Evelo Biosciences (EVLO)
Evolus, Inc. (EOLS)
Eyenovia, Inc. (EYEN)
Fortress Biotech, Inc. (FBIO)
Globus Medical, Inc. (GMED)
H3 Biomedicine, Inc. (Private)
Haemonetics Corporation (HAE)
Halozyme Therapeutics, Inc. (HALO)
Heron Therapeutics, Inc. (HRTX)
Insmed Incorporated (INSM)
Integra LifeSciences Holdings Corporation (IART)
Intellia Therapeutics, Inc. (NTLA)
Intrexon Corporation  (XON)
Inventiva SA (EPA: IVA)
Iovance Biotherapeutics, Inc. (IOVA)
K2M Group Holdings, Inc.  (KTWO)
Kadmon Holdings, Inc.  (KDMN)
Karyopharm Therapeutics Inc. (KPTI)
Keryx Biopharmaceuticals, Inc.  (KERX)
Kiniksa Pharmaceuticals (Private)
Kura Oncology, Inc.  (KURA)
Leap Therapeutics, Inc. (LPTX)
Loxo Oncology, Inc.  (LOXO)
Madrigal Pharmaceuticals, Inc. (MDGL)
Marinus Pharmaceuticals, Inc. (MRNS)
MediciNova, Inc. (MNOV)
Melinta Therapeutics, Inc. (MLNT)
Menlo Therapeutics Inc. (MNLO)
Minerva Neurosciences, Inc. (NERV)
MorphoSys AG (MOR)
Mustang Bio, Inc. (MBIO)
Myovant Sciences Ltd. (MYOV)
Neos Therapeutics, Inc. (NEOS)
NeuroRX, Inc. (Private)
NeuSpera Medical (Private)
Novan, Inc. (NOVN)
Nuvectra Corporation (NVTR)
Ocular Theapeutix, Inc. (OCUL)
Ovid Therapeutics Inc. (OVID)
Pfenex Inc. (PFNX)
Poxel SA (POXEL)
Proclara Biosciences (Private)
ProQR Therapeutics N.V. (PRQR)
Protagonist Therapeutics, Inc. (PTGX)
Proteon Therapeutics, Inc.  (PRTO)
Realm Therapeutics plc (RLM)
Regulus Therapeutics Inc. (RGLS)
Retrophin, Inc. (RTRX)
Revance Therapeutics, Inc. (RVNC)
RTI Surgical, Inc. (RTIX)
Sarepta Therapeutics, Inc. (SRPT)
Savara Inc. (SVRA)
Sienna Biopharmaceuticals, Inc. (SNNA)
Sol-Gel Technologies Ltd. (SLGL)
Sophiris Bio Inc. (SPHS)
Spring Bank Pharmaceuticals, Inc. (SBPH)
SQZ Biotech (Private)
SteadyMed Ltd. (STDY)
Strongbridge Biopharma plc (SBBP)
Summit Therapeutics plc (SMMT)
Syndax Pharmaceuticals, Inc.  (SNDX)
Synthorx (Private)
Syros Pharmaceuticals, Inc. (SYRS)
Teligent, Inc. (TLGT)
Trevana, Inc. (TRVN)
Ultragenyx Pharmaceutical Inc. (RARE)
Vanda Pharmaceuticals Inc. (VNDA)
Verona Pharma plc (VRNA)
Xencor, Inc. (XNCR)